CSChaitanya Srinivasan

Chaitanya Srinivasan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chaitanya Srinivasan has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fine-mapping candidate neuropsychiatric regulatory variants using cell type-aware comparative genomics

    by BaDoi N. Phan, Alyssa J. Lawler, Jing He, Ashley R. Brown, Irene M. Kaplow, Amanda Kowalczyk, Chaitanya Srinivasan, Grant A. Fox, Rajee Ganesan, Ziheng Chen, et al.

    : Measures of nucleotide sequence conservation across species are useful for identifying functional genomic loci, but can fail when regulatory function is maintained, often in a cell type-specific manner, even when sequence is not. We introduce CTACIT, the Cell Type-Aware Conservation Inference Toolkit, to identify trait-associated regulatory variants. CTACIT integrates sequence conservation scores with cell type-specific open chromatin data collected from a few mammalian species to impute function for hundreds more. Applying CTACIT to neuropsychiatric trait loci identifies higher heritability enrichment and more fine-mapped variants than nucleotide conservation and human chromatin data alone. Our in vivo reporter assays validate predictions for enhancers with risk variants near the DRD2 schizophrenia risk locus. By integrating genome conservation and multi-species open chromatin data, CTACIT prioritizes variants within regions of conserved regulatory function for in vivo characterization and addresses a major challenge in translating disease associations to mechanistic understanding. One-Sentence Summary: Regulatory functions conserved across mammals underlying caudate cell type evolution reveal functions of human risk variants.

  • Open Access

    Integrative multi-dimensional characterization of striatal projection neuron heterogeneity in adult brain

    by Jenesis Gayden, Stephanie Puig, Chaitanya Srinivasan, BaDoi N. Phan, Ghada Abdelhady, Silas A. Buck, Mackenzie C. Gamble, Hugo A. Tejeda, Yan Dong, Andreas R. Pfenning, et al.

    Summary: Striatal projection neurons (SPNs) are traditionally segregated into two subpopulations expressing dopamine (DA) D 1 -like or D 2 -like receptors. However, this dichotomy is challenged by recent evidence. Functional and expression studies raise important questions: do SPNs co-express different DA receptors, and do these differences reflect unique striatal spatial distributions and expression profiles? Using RNAscope in mouse striatum, we report heterogenous SPN subpopulations distributed across dorsal-ventral and rostral-caudal axes. SPN subpopulations co-express multiple DA receptors, including D 1 and D 2 (D1/2R) and D 1 and D 3 . Our integrative approach using single-nuclei multi-omics analyses provides a simple consensus to describe SPNs across diverse datasets, connecting it to complementary spatial mapping. Combining RNAscope and multi-omics shows D1/2R SPNs further separate into distinct subtypes according to spatial organization and conserved marker genes. Each SPN cell type contributes uniquely to genetic risk for neuropsychiatric diseases. Our results bridge anatomy and transcriptomics to offer new understandings of striatal neuron heterogeneity.


  • Open Access

    Relating enhancer genetic variation across mammals to complex phenotypes using machine learning

    by Irene M. Kaplow, Alyssa J. Lawler, Daniel E. Schäffer, Chaitanya Srinivasan, Morgan E. Wirthlin, BaDoi N. Phan, Xiaomeng Zhang, Kathleen Foley, Kavya Prasad, Ashley R. Brown, et al.

    Protein-coding differences between mammals often fail to explain phenotypic diversity, suggesting involvement of enhancers, often rapidly evolving regions that regulate gene expression. Identifying associations between enhancers and phenotypes is challenging because enhancer activity is context-dependent and may be conserved without much sequence conservation. We developed TACIT (Tissue-Aware Conservation Inference Toolkit) to associate open chromatin regions (OCRs) with phenotypes using predictions in hundreds of mammalian genomes from machine learning models trained to learn tissue-specific regulatory codes. Applying TACIT for motor cortex and parvalbumin-positive interneurons to neurological phenotypes revealed dozens of new OCR-phenotype associations. Many associated OCRs were near relevant genes, including brain size-associated OCRs near genes mutated in microcephaly or macrocephaly. Our work creates a forward genomics foundation for identifying candidate enhancers associated with phenotype evolution. One Sentence Summary A new machine learning-based approach associates enhancers with the evolution of brain size and behavior across mammals.


  • Top Cited Papers
    Open Access

    Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder

    by Marianne L. Seney, Sam-Moon Kim, Jill R. Glausier, Mariah A. Hildebrand, Xiangning Xue, Wei Zong, Jiebiao Wang, Micah A. Shelton, BaDoi N. Phan, Chaitanya Srinivasan, et al.


  • Open Access

    Addiction-Associated Genetic Variants Implicate Brain Cell Type- and Region-Specific Cis-Regulatory Elements in Addiction Neurobiology

    by Chaitanya Srinivasan, BaDoi N. Phan, Alyssa J. Lawler, Easwaran Ramamurthy, Michael Kleyman, Ashley R. Brown, Irene M. Kaplow, Morgan E. Wirthlin, Andreas R. Pfenning

    Recent large genome-wide association studies have identified multiple confident risk loci linked to addiction-associated behavioral traits. Most genetic variants linked to addiction-associated traits lie in noncoding regions of the genome, likely disruptingcis-regulatory element (CRE) function. CREs tend to be highly cell type-specific and may contribute to the functional development of the neural circuits underlying addiction. Yet, a systematic approach for predicting the impact of risk variants on the CREs of specific cell populations is lacking. To dissect the cell types and brain regions underlying addiction-associated traits, we applied stratified linkage disequilibrium score regression to compare genome-wide association studies to genomic regions collected from human and mouse assays for open chromatin, which is associated with CRE activity. We found enrichment of addiction-associated variants in putative CREs marked by open chromatin in neuronal (NeuN+) nuclei collected from multiple prefrontal cortical areas and striatal regions known to play major roles in reward and addiction. To further dissect the cell type-specific basis of addiction-associated traits, we also identified enrichments in human orthologs of open chromatin regions of female and male mouse neuronal subtypes: cortical excitatory, D1, D2, and PV. Last, we developed machine learning models to predict mouse cell type-specific open chromatin, enabling us to further categorize human NeuN+open chromatin regions into cortical excitatory or striatal D1 and D2 neurons and predict the functional impact of addiction-associated genetic variants. Our results suggest that different neuronal subtypes within the reward system play distinct roles in the variety of traits that contribute to addiction.SIGNIFICANCE STATEMENTWe combine statistical genetic and machine learning techniques to find that the predisposition to for nicotine, alcohol, and cannabis use behaviors can be partially explained by genetic variants in conserved regulatory elements within specific brain regions and neuronal subtypes of the reward system. Our computational framework can flexibly integrate open chromatin data across species to screen for putative causal variants in a cell type- and tissue-specific manner for numerous complex traits.